<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>40-STEP-III-OPIOID-ANALGESICS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="STEP III OPIOID ANALGESICS" code="N02A-002" /></DRUG1>
<DRUG2>
<CLASS name="AGONIST-ANTAGONIST OPIOIDS " code="NO2A-001" /></DRUG2>
<DESCRIPTION>Decrease of the antalgic effect due to competitive blocking of the receptors, with risk of appearance of a withdrawal syndrome</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>40-STEP-III-OPIOID-ANALGESICS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="STEP III OPIOID ANALGESICS" code="N02A-002" /></DRUG1>
<DRUG2>
<CLASS name="PARTIAL AGONIST OPIOIDS" code="PARAG" /></DRUG2>
<DESCRIPTION>Risk of decrease of the antalgic effect</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
</INTERACTIONS>
